Verfahren und Vorrichtungen zur Durchführung einer Analytischen Messung

EP3651162 Art B1 22. Juni 2022

Anmelder: Roche Diabetes Care GmbH, F. Hoffmann-La Roche AG 🇩🇪

Details

Veröffentlichungs-Nr.
EP3651162
Aktenzeichen
EP18205003
Anmeldetag
7. November 2018
Veröffentlichung
22. Juni 2022
Erteilung
22. Juni 2022
Rechtsraum
EP
IPC
G16H50/00A61B5/15
Offizieller Volltext

Abstract

A method of evaluating the suitability of a mobile device (112) for performing an analytical measurement based on a color formation reaction, a method of calibrating a mobile device (112) for performing an analytical measurement based on a color formation reaction and a method of performing an analytical measurement based on a color formation reaction in an optical test strip (120) by using a mobile device (112) are disclosed. Further disclosed are a suitability computer program, a calibration computer program and a measurement computer program as well as a mobile device (112) and a kit(110). The method of evaluating the suitability of a mobile device (112) for performing an analytical measurement based on a color formation reaction comprises:a) evaluating the capability of the mobile device (112) to have one or more relevant settings of the mobile device (112) controlled by a user's software running on the mobile device (112), the relevant settings pertaining to image raw data processing steps to be carried out by the mobile device (112), wherein the relevant settings include at least one of a color space transformation (132)and a tone mapping transformation (136);b) if the evaluation in step a) indicates that the mobile device (112) is capable of having the one or more relevant settings controlled by the user's software, providing at least one item of control information, the at least one item of control information indicating that the mobile device (112) is suitable for performing the analytical measurement; andc) if the evaluation in step a) indicates that the mobile device (112) is not capable of having the one or more relevant settings controlled by the user's software, providing at least one item of control information, the at least one item of control information indicating that the mobile device (112) is unsuitable for performing the analytical measurement.

Anmelder

Firmen
Roche Diabetes Care GmbH
F. Hoffmann-La Roche AG
Land
🇩🇪 Deutschland
🇩🇪 Roche Diabetes Care

Deutsche Tochtergesellschaft des Schweizer Roche-Konzerns, entwickelt Systeme zur Blutzuckermessung und Insulinabgabe für die Betreuung von Diabetespatienten.

974 Patente in unserer Datenbank

🇨🇭 Roche

Schweizer Pharma- und Diagnostikkonzern mit Sitz in Basel, gegründet 1896. Entwickelt Arzneimittel sowie Diagnostiksysteme für Labor- und klinische Anwendungen.

9.559 Patente in unserer Datenbank

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen